← Leaderboards
Hunter Wessells
University Of Arizona
$9,133,560
Attributed
$14,749,644
Total exposure
10
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,749,644 · 10
By mechanism
R01$7,152,870 · 4
U01$4,904,676 · 1
TL1$1,598,634 · 1
R21$530,600 · 2
T32$481,663 · 1
R56$81,201 · 1
Top collaborators
- Aruna V Sarma11 shared
- Jonathan D. Harper8 shared
- James Hotaling3 shared
- Stephen K. Van Den Eeden3 shared
Most similar at University Of Arizona
Same institution · by research overlap
- Anna R Giuliano$35,098,080
- Theresa Renee Anthony$22,377,843
- Kathleen L Melde$1,062,479
- Janet M Roveda$2,031,932
- Hao Xin$1,406,487
Others in their field
Top investigators on “Cohort”
- David R. Weir · University Of Michigan At Ann Arbor$406,814,098
- George R Seage · Abt Associates, Inc.$297,656,361
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$242,146,554
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$227,738,417
- Lawrence Corey · Fred Hutchinson Cancer Center$227,738,417
- James Dennis Neaton · Northwestern University$203,539,316
Research focus
CohortDiabetes MellitusNational Institute Of Diabetes And Digestive And Kidney DiseasesParticipantSymptomsEpidemiologyFutureQuestionnairesCostMultidisciplinaryUrologicPreventionFunctional DisorderBiologicalComplexUrologyFollow-UpPrevalenceAffectPhenotypeSeveritiesInsightDiabeticHealthcare Systems
Grant awards (41)
NRSA Training Core$718,117
TL1 · FY2025 · DK · contact PI
NRSA Training Core$160,023
TL1 · FY2025 · DK · contact PI
NRSA Training Core$720,494
TL1 · FY2024 · DK · contact PI
UroEDIC Bladder: Bladder Dysfunction in Type 1 Diabetes$544,288
R01 · FY2024 · DK
UW USDRN Clinical Center$476,733
U01 · FY2024 · DK
UroEDIC Bladder: Bladder Dysfunction in Type 1 Diabetes$619,441
R01 · FY2023 · DK
UW USDRN Clinical Center$499,999
U01 · FY2023 · DK
UroEDIC Bladder: Bladder Dysfunction in Type 1 Diabetes$650,157
R01 · FY2022 · DK
UW USDRN Clinical Center$612,064
U01 · FY2022 · DK
UroEDIC Bladder: Bladder Dysfunction in Type 1 Diabetes$722,963
R01 · FY2021 · DK
University of Washington USDRN Clinical Center (UWCC)$647,752
U01 · FY2020 · DK
University of Washington USDRN Clinical Center (UWCC)$666,966
U01 · FY2019 · DK
Susceptibility Genes for Erectile Dysfunction$245,331
R01 · FY2019 · DK · contact PI
University of Washington USDRN Clinical Center (UWCC)$630,475
U01 · FY2018 · DK
University of Washington USDRN Clinical Center (UWCC)$689,062
U01 · FY2017 · DK
Susceptibility Genes for Erectile Dysfunction$271,043
R01 · FY2017 · DK · contact PI
University of Washington USDRN Clinical Center (UWCC)$681,625
U01 · FY2016 · DK
Susceptibility Genes for Erectile Dysfunction$252,005
R01 · FY2016 · DK · contact PI
Multi-disciplinary Training in Benign Urology$83,857
T32 · FY2016 · DK · contact PI
UroEDIC III: Mechanisms and Impact of Urological Complications in Type 1 Diabetes$81,201
R56 · FY2016 · DK · contact PI
Multi-disciplinary Training in Benign Urology$32,962
T32 · FY2015 · DK · contact PI
Multi-disciplinary Training in Benign Urology$119,349
T32 · FY2014 · DK · contact PI
Uro-EDICII: Risk and Progression of Urologic Complications in Type 1- Diabetes$533,757
R01 · FY2013 · DK · contact PI
Multi-disciplinary Training in Benign Urology$110,135
T32 · FY2013 · DK · contact PI
Uro-EDICII: Risk and Progression of Urologic Complications in Type 1- Diabetes$513,604
R01 · FY2012 · DK · contact PI
Multi-disciplinary Training in Benign Urology$135,360
T32 · FY2012 · DK · contact PI
Uro-EDICII: Risk and Progression of Urologic Complications in Type 1- Diabetes$500,195
R01 · FY2011 · DK · contact PI
Uro-EDICII: Risk and Progression of Urologic Complications in Type 1- Diabetes$515,381
R01 · FY2010 · DK · contact PI
Uro-EDICII: Risk and Progression of Urologic Complications in Type 1- Diabetes$62,000
R01 · FY2010 · DK · contact PI
Uro-EDICII: Risk and Progression of Urologic Complications in Type 1- Diabetes$560,000
R01 · FY2009 · DK · contact PI
Neural Melanocortin Signaling and Erectile Function$151,600
R21 · FY2005 · DK
Immortalized Human Cavernosal Endothelial Cells$113,700
R21 · FY2005 · DK
GENE THERAPY OF DIABETIC PENILE ENDOTHELIAL DYSFUNCTION$228,000
R01 · FY2004 · DK
Neural Melanocortin Signaling and Erectile Function$151,600
R21 · FY2004 · DK
Immortalized Human Cavernosal Endothelial Cells$113,700
R21 · FY2004 · DK
GENE THERAPY OF DIABETIC PENILE ENDOTHELIAL DYSFUNCTION$228,000
R01 · FY2003 · DK
GENE THERAPY OF DIABETIC PENILE ENDOTHELIAL DYSFUNCTION$228,000
R01 · FY2002 · DK
GENE THERAPY OF DIABETIC PENILE ENDOTHELIAL DYSFUNCTION$228,000
R01 · FY2001 · DK
GENE THERAPY OF DIABETIC PENILE ENDOTHELIAL DYSFUNCTION$25,000
R01 · FY2001 · DK
GENE THERAPY OF DIABETIC PENILE ENDOTHELIAL DYSFUNCTION$177,487
R01 · FY2000 · DK
GENE THERAPY OF DIABETIC PENILE ENDOTHELIAL DYSFUNCTION$48,218
R01 · FY2000 · DK